Evidence map›Paper›PMID 38654680›Full record

Trial reportThe British journal of nutrition2024

Effects of a diverse prebiotic fibre supplement on HbA1c, insulin sensitivity and inflammatory biomarkers in pre-diabetes: a pilot placebo-controlled randomised clinical trial.

Caitlin Victoria Hall, John Luke Twelves, Manish Saxena, Leonardo Scapozza, Thomas Gurry

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The British journal of nutrition, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Review
  6. Probiotics,Metabolism open · 2025
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Caitlin Victoria HallMyota GmbH, Berlin, Germany.ORCID 0000-0001-7013-6446
John Luke TwelvesLindus Health Limited, London, UK.
Manish SaxenaWilliam Harvey Research Institute, Barts NIHR Biomedical Research Centre, Queen Mary University of London, London, UK.
Leonardo ScapozzaPharmaceutical Biochemistry Group, School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland.
Thomas GurryMyota GmbH, Berlin, Germany.
University of Geneva · CHQueen Mary University of London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prebiotic fibre represents a promising and efficacious treatment to manage pre-diabetes, acting via complementary pathways involving the gut microbiome and viscosity-related properties. In this study, we evaluated the effect of using a diverse prebiotic fibre supplement on glycaemic, lipid and inflammatory biomarkers in patients with pre-diabetes. Sixty-six patients diagnosed with pre-diabetes (yet not receiving glucose-lowering medications) were randomised into treatment (thirty-three) and placebo (thirty-three) interventions. Participants in the treatment arm consumed 20 g/d of a diverse prebiotic fibre supplement, and participants in the placebo arm consumed 2 g/d of cellulose for 24 weeks. A total of fifty-one and forty-eight participants completed the week 16 and week 24 visits, respectively. The intervention was well tolerated, with a high average adherence rate across groups. Our results extend upon previous work, showing a significant change in glycated haemoglobin (HbA1c) in the treatment group but only in participants with lower baseline HbA1c levels (< 6 % HbA1c) (

Indexed as

BiomarkersDietary FiberDietary SupplementsGlycated HemoglobinInsulin ResistancePrebioticsPrediabetic StateAdultAgedBlood GlucoseC-Reactive ProteinDouble-Blind MethodFemaleHumansInflammationMaleBiomarkersBlood GlucoseC-Reactive ProteinDietary FiberGlycated Hemoglobinhemoglobin A1c protein, humanPrebioticsGut microbiomePlacebo-controlledPrebiotic fibre supplementPre-diabetesRandomised controlled trial

Identifiers

PMID38654680
PMCPMC11420881
OpenAlexW4395077361

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.